Therapeutic pathology
31 – 40 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
- Contribution to journal › Article
-
Mark
Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression
- Contribution to journal › Article
-
Mark
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
- Contribution to journal › Article
- 2022
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
- Contribution to journal › Article
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
- Contribution to journal › Article
-
Mark
A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC
- Contribution to journal › Article
-
Mark
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
- Contribution to journal › Article
-
Mark
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer : longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
- Contribution to journal › Article
-
Mark
Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular Matrix
- Contribution to journal › Article
